https://nedarazavi.home.blog/2021/07/20/new-genome-sequencing-approach-to-heart-disease-risk-assessment/2021-07-20T05:38:52+00:00monthlyhttps://nedarazavi.home.blog/2021/07/07/genomics-for-gene-therapy-bluebird-bio-gene-therapy-for-beta-thalasem/2021-07-07T04:21:14+00:00monthlyhttps://nedarazavi.home.blog/2020/07/09/key-aspects-of-a-personalized-marketing-campaign/2020-07-09T06:58:58+00:00monthlyhttps://nedarazavi.home.blog/2020/06/29/the-role-of-data-in-driving-personalized-marketing/2020-06-29T23:07:20+00:00monthlyhttps://nedarazavi.home.blog/2020/06/13/the-main-elements-of-successful-personalization-marketing/2020-06-13T15:52:59+00:00monthlyhttps://nedarazavi.home.blog/2020/06/04/programmatic-technology-to-change-the-healthcare-marketing-landscape/2020-06-04T05:02:02+00:00monthlyhttps://nedarazavi.home.blog/2020/05/29/categorizing-consumers-for-a-personalized-marketing-campaign/2020-05-29T22:02:39+00:00monthlyhttps://nedarazavi.home.blog/2020/05/06/bluebird-bio-launches-first-gene-therapy-for-beta-thalassemia/2020-05-06T05:09:09+00:00monthlyhttps://nedarazavi.home.blog/2020/04/13/basics-of-personalized-marketing/2020-04-13T23:32:37+00:00monthlyhttps://nedarazavi.home.blog/2019/12/19/stanford-universitys-genetics-and-genomics-professional-certificate/2019-12-19T21:26:22+00:00monthlyhttps://nedarazavi.home.blog/about/2019-06-18T05:26:19+00:00weekly0.6https://nedarazavi.home.blogdaily1.02021-07-20T05:38:52+00:00